Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
Author(s) -
Thiago Ferreira de Souza,
Thiago Quinaglia,
Felipe Osório Costa,
Ravi V. Shah,
Tomas G. Neilan,
Lı́cio A. Velloso,
Wilson Nadruz,
Fabrício Brenelli,
Andrei C. Spósito,
José R. MatosSouza,
Fernando Cendes,
Otávio Rizzi Coelho,
Michael JeroschHerold,
Otávio R. CoelhoFilho
Publication year - 2018
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2018.05.012
Subject(s) - ejection fraction , medicine , cardiology , heart failure , magnetic resonance imaging , anthracycline , cardiac magnetic resonance imaging , atrophy , breast cancer , cancer , radiology
The goal of this study was to demonstrate that cardiac magnetic resonance could reveal anthracycline-induced early tissue remodeling and its relation to cardiac dysfunction and left ventricular (LV) atrophy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom